3′‐azido‐3′‐deoxythymidine induces deletions in L5178Y mouse lymphoma cells
- 19 March 2007
- journal article
- research article
- Published by Wiley in Environmental and Molecular Mutagenesis
- Vol. 48 (3-4) , 248-257
- https://doi.org/10.1002/em.20263
Abstract
3′‐Azido‐3′‐deoxythymidine (AZT), a nucleoside analogue used for the treatment of acquired immunodeficiency syndrome (AIDS), induced a significant dose‐related increase in the thymidine kinase (Tk) mutant frequency (MF) in L5178Y/Tk+/− 3.7.2C mouse lymphoma cells. Treatment with 1 mg/ml (3,742 μM) AZT for 24 hr resulted in a MF of 407 × 10−6 compared to a control MF of 84 × 10−6. The MFs of the large and small colony mutants resulting from AZT exposure were 142 × 10−6 and 265 × 10−6, respectively. One hundred and fifty mutants from the 1 mg/ml (3,742 μM) AZT‐treated culture and sixty‐nine mutants from independent untreated cultures were isolated and analyzed. LOH analysis using a heteromorphic microsatellite locus located in the Tk gene was performed to determine the presence or absence of the Tk+ allele. Eight other microsatellite markers spanning the entire mouse chromosome 11 also were examined for heterozygosity to determine the extent of LOH. In addition, Tk gene dosage analysis was conducted using Real‐Time PCR in those mutants showing LOH at the Tk locus. The presence of only one Tk allele based on Real‐Time PCR indicated that the mutant resulted from deletion while the presence of two alleles was consistent with a recombination event. More mutants from the AZT‐treated culture showed Tk LOH than did independent mutants from the untreated cultures (91% vs. 64%) and the induced mutants also showed distinct chromosome 11 LOH patterns. The mutation spectrum of mutants from AZT‐treated cells was also significantly different from that of spontaneous mutants. More deletions and fewer intragenic mutations were observed in the mutants from the AZT‐treated culture than independent mutants from the untreated control. Our data indicate that AZT primarily induced LOH mutations in L5178Y mouse lymphoma cells and a large number of LOH mutations resulted from deletions. Environ. Mol. Mutagen., 2007. Published 2007 Wiley‐Liss, Inc.Keywords
This publication has 52 references indexed in Scilit:
- Multicolor spectral karyotyping of the L5178YTk+/−-3.7.2C mouse lymphoma cell lineEnvironmental and Molecular Mutagenesis, 2005
- Mouse lymphoma thymidine kinase gene mutation assay: Follow‐up meeting of the international workshop on Genotoxicity testing—Aberdeen, Scotland, 2003—Assay acceptance criteria, positive controls, and data evaluationEnvironmental and Molecular Mutagenesis, 2005
- Analysis of mutations in the Tk gene of Tk+/− mice treated as neonates with 3′-azido-3′-deoxythymidine (AZT)Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2004
- Deletion, rearrangement, and gene conversion; genetic consequences of chromosomal double‐strand breaks in human cellsEnvironmental and Molecular Mutagenesis, 2003
- Occupational Exposure to HIV and Post-exposure Prophylaxis in Healthcare WorkersOccupational Medicine, 2000
- Identification and chromosomal assignment of two heterozygous mutations in the Trp53 gene in L5178Y\Tk +\−-3.7.2C mouse lymphoma cellsMutagenesis, 1998
- The mouse lymphoma L5178Y Tk+/− cell line is heterozygous for a codon 170 mutation in the p53 tumor suppressor geneMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1997
- Classification of mutations at the HLA‐A locus by use of the polymerase chain reactionEnvironmental and Molecular Mutagenesis, 1993
- Statistical test for the comparison of samples from mutational spectraJournal of Molecular Biology, 1987
- Cytogenetic analysis of the L5178Y/TK+/− → TK−/− mouse lymphoma mutagenesis assay systemMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1981